Predictions
Zoetis Inc. A
Start price
Target price
Perf. (%)
€176.92
03.08.22
03.08.22
€190.00
03.08.23
03.08.23
-6.34%
03.08.23
03.08.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€49.24
31.07.22
31.07.22
€50.00
31.07.23
31.07.23
-31.05%
22.05.23
22.05.23
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€49.74
20.07.22
20.07.22
€55.00
20.07.23
20.07.23
-33.55%
21.07.23
21.07.23
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Johnson & Johnson
Start price
Target price
Perf. (%)
€175.60
13.07.22
13.07.22
€168.00
13.07.23
13.07.23
-19.13%
13.07.23
13.07.23
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€613.40
10.07.22
10.07.22
€999.00
10.07.23
10.07.23
-6.06%
23.07.22
23.07.22
Could be very worthwhile Investment >20% year
AbbVie Inc.
Start price
Target price
Perf. (%)
€137.98
05.06.22
05.06.22
€155.00
05.06.23
05.06.23
-7.09%
06.06.23
06.06.23
Could be worthwhile Investment >10% per year
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€72.88
16.05.22
16.05.22
-
16.05.23
16.05.23
-2.92%
27.05.22
27.05.22
Probably not worthwhile Investment
Business model of the past or high risk
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Johnson & Johnson
Start price
Target price
Perf. (%)
€174.42
27.04.22
27.04.22
€190.00
27.04.23
27.04.23
-15.38%
27.04.23
27.04.23
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.65
07.04.22
07.04.22
€56.00
07.04.23
07.04.23
-24.58%
08.04.23
08.04.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€248.30
06.04.22
06.04.22
-
06.04.23
06.04.23
18.49%
06.04.23
06.04.23
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€638.60
06.04.22
06.04.22
-
06.04.23
06.04.23
17.91%
06.04.23
06.04.23
Pfizer Inc.
Start price
Target price
Perf. (%)
€46.84
04.04.22
04.04.22
€55.00
04.04.23
04.04.23
2.48%
16.04.22
16.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€66.35
25.03.22
25.03.22
-
25.04.22
25.04.22
6.07%
26.04.22
26.04.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Pfizer Inc.
Start price
Target price
Perf. (%)
€47.88
25.03.22
25.03.22
€64.00
25.03.23
25.03.23
-21.14%
27.03.23
27.03.23
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€48.26
23.03.22
23.03.22
€55.00
23.03.23
23.03.23
-3.61%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€213.80
18.01.22
18.01.22
€350.00
18.01.23
18.01.23
47.33%
23.09.22
23.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Biogen Inc.
Start price
Target price
Perf. (%)
€192.48
12.01.22
12.01.22
€240.00
12.01.23
12.01.23
-0.52%
16.02.22
16.02.22
Could be worthwhile Investment >10% per year
Known brand
Biogen Inc.
Start price
Target price
Perf. (%)
€194.22
12.01.22
12.01.22
€240.00
12.01.23
12.01.23
-0.90%
12.01.22
12.01.22
Could be worthwhile Investment >10% per year
Known brand
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
122.17%
04.07.24
04.07.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.01
03.01.22
03.01.22
€78.00
03.01.23
03.01.23
-2.98%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Johnson & Johnson
Start price
Target price
Perf. (%)
€149.96
28.12.21
28.12.21
-
28.12.22
28.12.22
10.44%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
Biogen Inc.
Start price
Target price
Perf. (%)
€208.25
27.12.21
27.12.21
€215.00
27.12.22
27.12.22
23.82%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year